Abrdn Healthcare Investors (HQH) Stock Score, Valuation & Financial Research
Abrdn Healthcare Investors is in the Financial Services sector and Asset Management industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 71/100.
Quick answer for HQH
Abrdn Healthcare Investors currently has a Wall Street Score of 71/100. The stored market price is $21.77. Its financial score is 20/100. Its valuation score is 100/100. These figures are a research snapshot, not a buy or sell recommendation.
What Abrdn Healthcare Investors does
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed
HQH financial snapshot
- Wall Street Score:
- 71/100
- Current price:
- $21.77
- Market capitalization:
- $1.25B
- Revenue:
- $32.5M
- Net income:
- $331.6M
- Free cash flow:
- $0
- Cash:
- $59
- Total debt:
- $0
- EPS:
- 6.20
- P/E ratio:
- 3.5x
- Financial score:
- 20/100
- Valuation score:
- 100/100
- Revenue score:
- 55/100
What stands out
- Reported year-over-year revenue growth is -0.7%.
- Free cash flow is $0, showing positive cash generation.
- The balance sheet shows $59 of cash versus $0 of total debt, leaving more cash than debt.
- The current research record carries a listed fund vehicle warning, which should be reviewed alongside the score.
What the numbers mean
Its current valuation score is 100/100, which Wall Street Score classifies as strong within the model's valuation framework.
The financial score is 20/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-07.
How to research HQH
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.